154 related articles for article (PubMed ID: 26600650)
1. Myopathy induced by statin-ezetimibe combination: Evaluation of potential risk factors.
Brahmachari B; Chatterjee S
Indian J Pharmacol; 2015; 47(5):563-4. PubMed ID: 26600650
[TBL] [Abstract][Full Text] [Related]
2. Ezetimibe-associated myopathy in monotherapy and in combination with a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.
Simard C; Poirier P
Can J Cardiol; 2006 Feb; 22(2):141-4. PubMed ID: 16485049
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of cholesteryl ester transfer protein inhibition, statin or ezetimibe on lipid factors: The ACCENTUATE trial.
Nicholls SJ; Ray KK; Ballantyne CM; Beacham LA; Miller DL; Ruotolo G; Nissen SE; Riesmeyer JS;
Atherosclerosis; 2017 Jun; 261():12-18. PubMed ID: 28412650
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the efficacy and safety of atorvastatin + ezetimibe in a fixed-dose combination for the treatment of hypercholesterolemia.
Ma YB; Chan P; Zhang Y; Tomlinson B; Liu Z
Expert Opin Pharmacother; 2019 Jun; 20(8):917-928. PubMed ID: 30908086
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial.
Nissen SE; Stroes E; Dent-Acosta RE; Rosenson RS; Lehman SJ; Sattar N; Preiss D; Bruckert E; Ceška R; Lepor N; Ballantyne CM; Gouni-Berthold I; Elliott M; Brennan DM; Wasserman SM; Somaratne R; Scott R; Stein EA;
JAMA; 2016 Apr; 315(15):1580-90. PubMed ID: 27039291
[TBL] [Abstract][Full Text] [Related]
6. [Rhabdomyolysis associated to combined ezetimibe-statin treatment].
Piedra León M; García Unzueta MT; Otero Martínez M; Amado Señaris JA
Rev Clin Esp; 2007 Sep; 207(8):425-6. PubMed ID: 17688879
[No Abstract] [Full Text] [Related]
7. Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy.
Ballantyne CM; Laufs U; Ray KK; Leiter LA; Bays HE; Goldberg AC; Stroes ES; MacDougall D; Zhao X; Catapano AL
Eur J Prev Cardiol; 2020 Apr; 27(6):593-603. PubMed ID: 31357887
[TBL] [Abstract][Full Text] [Related]
8. Medication Adherence/Persistence and Demographics of Japanese Dyslipidemia Patients on Statin-Ezetimibe as a Separate Pill Combination Lipid-Lowering Therapy - An Observational Pharmacy Claims Database Study.
Umeda T; Hayashi A; Fujimoto G; Piao Y; Matsui N; Tokita S
Circ J; 2019 Jul; 83(8):1689-1697. PubMed ID: 31281135
[TBL] [Abstract][Full Text] [Related]
9. Comparative efficacy and adverse effects of the addition of ezetimibe to statin versus statin titration in chronic kidney disease patients.
Suzuki H; Watanabe Y; Kumagai H; Shuto H
Ther Adv Cardiovasc Dis; 2013 Dec; 7(6):306-15. PubMed ID: 24280596
[TBL] [Abstract][Full Text] [Related]
10. Available oral lipid-lowering agents could bring most high-risk patients to target: an estimate based on the Dyslipidemia International Study II-Italy.
De Ferrari GM; Perna GP; Nicosia A; Guasti L; Casu G; Cuccia C; Picco F; Strazzella C; Totaro R; Cercone S; Canullo L; Horack M; Lautsch D; Gitt AK; Di Biase M
J Cardiovasc Med (Hagerstown); 2018 Sep; 19(9):485-490. PubMed ID: 29917002
[TBL] [Abstract][Full Text] [Related]
11. Comparison of PCSK9 Inhibitor Evolocumab vs Ezetimibe in Statin-Intolerant Patients: Design of the Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin-Intolerant Subjects 3 (GAUSS-3) Trial.
Nissen SE; Dent-Acosta RE; Rosenson RS; Stroes E; Sattar N; Preiss D; Mancini GB; Ballantyne CM; Catapano A; Gouni-Berthold I; Stein EA; Xue A; Wasserman SM; Scott R; Thompson PD;
Clin Cardiol; 2016 Mar; 39(3):137-44. PubMed ID: 26946077
[TBL] [Abstract][Full Text] [Related]
12. Rechallenging Statin Therapy in Veterans With Statin-Induced Myopathy Post Vitamin D Replenishment.
Kang JH; Nguyen QN; Mutka J; Le QA
J Pharm Pract; 2017 Oct; 30(5):521-527. PubMed ID: 27798247
[TBL] [Abstract][Full Text] [Related]
13. Synergistic effect of ezetimibe addition on coronary atheroma regression in patients with prior statin therapy: Subanalysis of PRECISE-IVUS trial.
Tsujita K; Yamanaga K; Komura N; Sakamoto K; Sugiyama S; Sumida H; Shimomura H; Yamashita T; Oka H; Nakao K; Nakamura S; Ishihara M; Matsui K; Sakaino N; Nakamura N; Yamamoto N; Koide S; Matsumura T; Fujimoto K; Tsunoda R; Morikami Y; Matsuyama K; Oshima S; Kaikita K; Hokimoto S; Ogawa H;
Eur J Prev Cardiol; 2016 Sep; 23(14):1524-8. PubMed ID: 27296705
[TBL] [Abstract][Full Text] [Related]
14. Comparison of signal detection between statin and statin/ezetimibe fixed-dose combination using the Korea Adverse Events Reporting System Database, 2005 - 2016
.
Ha D; Lee YJ; Chun Y; Shin JY
Int J Clin Pharmacol Ther; 2019 Oct; 57(10):489-499. PubMed ID: 31272527
[TBL] [Abstract][Full Text] [Related]
15. Low-density lipoprotein cholesterol targeting with pitavastatin + ezetimibe for patients with acute coronary syndrome and dyslipidaemia: the HIJ-PROPER study, a prospective, open-label, randomized trial.
Hagiwara N; Kawada-Watanabe E; Koyanagi R; Arashi H; Yamaguchi J; Nakao K; Tobaru T; Tanaka H; Oka T; Endoh Y; Saito K; Uchida T; Matsui K; Ogawa H
Eur Heart J; 2017 Aug; 38(29):2264-2276. PubMed ID: 28430910
[TBL] [Abstract][Full Text] [Related]
16. [Myopathy due to statins, a dose-dependent effect, and of what kind?].
León Vázquez F; Llanes De Torres R; Morón Merchante I
Aten Primaria; 2002; 30(3):188. PubMed ID: 12139858
[No Abstract] [Full Text] [Related]
17. Statin-induced myopathy: a review and update.
Abd TT; Jacobson TA
Expert Opin Drug Saf; 2011 May; 10(3):373-87. PubMed ID: 21342078
[TBL] [Abstract][Full Text] [Related]
18. Non-statin lipid-lowering therapy over time in very-high-risk patients: effectiveness of fixed-dose statin/ezetimibe compared to separate pill combination on LDL-C.
Katzmann JL; Sorio-Vilela F; Dornstauder E; Fraas U; Smieszek T; Zappacosta S; Laufs U
Clin Res Cardiol; 2022 Mar; 111(3):243-252. PubMed ID: 32949286
[TBL] [Abstract][Full Text] [Related]
19. [FIXED COMBINATION ATORVASTATIN-EZETIMIBE (ATOZET®)].
Scheen AJ
Rev Med Liege; 2016 Jan; 71(1):47-52. PubMed ID: 26983314
[TBL] [Abstract][Full Text] [Related]
20. Statin myopathy: a lipid clinic experience on the tolerability of statin rechallenge.
Fung EC; Crook MA
Cardiovasc Ther; 2012 Oct; 30(5):e212-8. PubMed ID: 21884002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
